GeneDx Holdings Corp (WGS)

Currency in USD
45.46
-3.78(-7.68%)
Closed·
46.35+0.89(+1.96%)
·

WGS Earnings

Latest Release
Nov 09, 2026
EPS / Forecast
-0.41 / 0.07
Revenue / Forecast
123.1M / 122.98M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2026--/0.391--/136.07M----Free Sign Up
09/2026-0.410/0.070123.10M/122.98M-685.71%+0.1%Free Sign Up
06/2026-0.280/-0.140114.40M/111.01M-100%+3.05%Free Sign Up
03/2026-0.280/-0.010102.30M/112.45M-2,700%-9.03%Free Sign Up
12/2025-0.610/0.090121.00M/120.55M-777.78%+0.37%Free Sign Up
09/20250.490/0.410116.74M/104.33M+19.51%+11.89%Free Sign Up
06/20250.500/0.120102.70M/85.45M+316.67%+20.19%Free Sign Up
03/2025-0.230/0.06087.10M/78.00M-483.33%+11.67%Free Sign Up
12/20240.080/-0.48095.30M/61.70M+116.67%+54.46%Free Sign Up
09/20240.040/-0.57076.60M/58.79M+107.04%+30.29%Free Sign Up

All numbers in USD

GeneDx Holdings Corp Earnings Call Summary for Q3/2026

  • GeneDx Q3 revenue hit $123.1M, matching estimates, but missed EPS at -$0.41 vs. $0.07 forecast; shares fell 8.25% after hours to $60.3.
  • Adjusted gross margin expanded to 72% from 70% in Q2; adjusted net income turned positive at $8.6M, up from $8.2M loss in Q1.
  • Company raised FY adjusted gross margin guidance to ~71% and net income to at least $12M; reaffirmed revenue at $475M-$490M, low end expected.
  • Q4 guidance: revenue of at least $135M, exome/genome revenue of $121M, adjusted net income of ~$12M, and 34,500 test volume.
  • Revenue-cycle overhaul prioritizing paid volume over raw growth may pressure near-term results; PAMA headwind expected in 2027 offset by RCM gains.
Last Updated: 11/10/2026, 06:36 AM
Read Full Transcript

FAQ

What Is GeneDx Holdings's Earnings Per Share (TTM)?

The GeneDx Holdings EPS (TTM) is -3.76.

When Is The Next GeneDx Holdings Earnings Date?

GeneDx Holdings will release its next earnings report on Mar 16, 2027.

What Is GeneDx Holdings’s Revenue Forecasts For Upcoming Quarters?

GeneDx Holdings’s revenue forecast is 136.07M.

How Did GeneDx Holdings React to the Company's Latest Earnings Report?

GeneDx Holdings reported a -685.71% EPS surprise and a +0.1% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -12.09%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.